Greenwich LifeSciences In... (GLSI)

11.70

-0.52 (-4.26%)

At close: Mar 03, 2025, 3:59 PM

11.70

0.00%

After-hours: Mar 03, 2025, 04:00 PM EST

Greenwich LifeSciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-8.89M	-7.83M	-4.57M	-1.86M	-3.43M	-1.69M	-1.57M
Depreciation & Amortization	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K
Stock-Based Compensation	2.38M	1.74M	660.58K	677.99K	194.94K	n/a	n/a
Other Working Capital	-3.97K	-122.27K	141.57K	120.95K	2.54M	1.49M	1.3M
Other Non-Cash Items	n/a	1.75M	1.19M	777.76K	-2	-73.75K	-137.7K
Deferred Income Tax	n/a	-1.75M	-1.19M	-777.76K	n/a	n/a	n/a
Change in Working Capital	31.5K	-122.27K	-385.17K	28.4K	2.93M	1.57M	1.45M
Operating Cash Flow	-6.48M	-6.2M	-4.29M	-1.15M	-293.27K	-114.95K	-120.85K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-7.54M	n/a	n/a	n/a	n/a	-90K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	2.84M	-360K	215K	200K	-129.84K
Financial Cash Flow	n/a	-7.54M	2.84M	29.81M	215K	200K	-129.84K
Net Cash Flow	-6.48M	-13.74M	-1.46M	28.65M	-78.27K	85.05K	-250.69K
Free Cash Flow	-6.48M	-6.2M	-4.29M	-1.15M	-293.27K	-114.95K	-120.85K